Bailed Out by Science

By Richard Gallagher Bailed Out by Science The US healthcare system is hurting, but research can come to its rescue. Science won’t feature extensively in talks over the coming weeks, but it is central to effectively rehabilitate the healthcare system. It’s a daunting task, but the ailing beast that is the US healthcare system must be brought to heel. Its feverish appetite for dollars needs to be curbed while getting t

Written byRichard Gallagher
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

It’s a daunting task, but the ailing beast that is the US healthcare system must be brought to heel. Its feverish appetite for dollars needs to be curbed while getting the brute to recognize everyone in society is entitled to attention.

Science won’t feature extensively in discussions over the coming weeks, but it is central to effectively rehabilitate the monster. So in this month’s Opinion articles, we offer two sets of recommendations on science to the warriors of Congress who are crusading for just reform.

Healthcare reform: 2 views

Darwin, ha ha

The Vaccine Conundrum

In the first, Dennis Cotter and colleagues from the non-profit Medical Technology & Practice Patterns Institute (MTPPI), illustrate vividly one of the struggles: the battle with mindless consumption. They describe in "Striking the right balance" the unnecessary, possibly harmful, and inordinately expensive over prescription of Epogen, a synthetic form of erythropoietin that regulates red blood ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies